ADAM CROWSON: Open Payments
NPI 1225635329 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 46 payments from 16 companies in 2025. Trend: 2023 $1,370 · 2024 $1,270 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $172 |
| PFIZER INC. | 5 | $99 |
| Dexcom, Inc. | 3 | $94 |
| ABBVIE INC. | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Biosense Webster, Inc. | 2 | $72 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 3 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Amgen Inc. | 2 | $30 |
Products named: Ozempic, Dexcom G6 Transmitter, NURTEC ODT, CARTO 3, Rybelsus, Auvelity, QULIPTA, XIFAXAN.
Industry payments across FL — which companies pay providers there.
